X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://ir.biocryst.com/news-releases/news-release-details/fda-grants-orphan-drug-designation-biocrysts-alk-2-inhibitor
https://endpts.com/enhertu-strikes-again-with-a-phiii-success-in-another-breast-cancer-population/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203007
https://www.ema.europa.eu/en/news/no-change-product-information-breast-cancer-medicine-tyverb-following-re-assessment-data
https://www.fiercepharma.com/marketing/puma-biotech-s-nerlynx-suffers-a-terrible-quarter-what-gives
https://www.ema.europa.eu/en/news/re-analysis-data-use-breast-cancer-medicine-tyverb-following-treatment-trastuzumab
https://www.biospectrumasia.com/news/25/12513/hetero-launches-generic-lapatinib-in-india.html
https://www.businesswire.com/news/home/20181217005783/en/Puma-Biotechnology-Announces-Top-Line-Results-Phase/
http://www.fiercepharma.com/pharma-asia/aslan-poses-positive-top-line-varlitinib-phase-2-data-breast-cancer
http://www.pmlive.com/pharma_news/pfizers_first-in-class_breast_cancer_therapy_wins_eu_licensing_1176260?
http://www.forbes.com/sites/elaineschattner/2015/11/24/why-many-new-cancer-drugs-dont-have-to-cost-so-much/?ss=pharma-healthcare
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/swiss-drugmaker-roche-launches-costliest-cancer-drugs-in-india/articleshow/49927222.cms
http://www.fiercepharma.com/story/us-cancer-drug-prices-3x-higher-europe-study/2015-09-24
http://in.reuters.com/article/2015/09/22/us-health-pharmaceuticals-cancer-usa-idINKCN0RM1EC20150922
Market Place
Share 
